Efficacy of Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) against circulating microfilariae in dogs infected with Dirofilaria immitis.

Authors

Raj Packianathan, Kyu Sung Ahn, SungShik Shin, Hyeonjo Cho, Jihae Kim, Jessica Rodriguez, Thomas Geurden

Published in

Parasites & vectors. Volume 19. Issue 1. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

Canine heartworm disease remains a global threat despite the availability of multiple preventive options, a challenge compounded by the emergence of macrocyclic lactone-resistant heartworm strains, especially in the USA. Circulating microfilariae play a pivotal role in heartworm transmission, serving as a continuous infection reservoir for mosquito vectors. Therefore, targeting this life cycle stage is critical in the framework of a comprehensive and multimodal heartworm prevention strategy.
A randomised, blinded, negative-controlled laboratory study evaluated the efficacy of Simparica Trio® (Zoetis Inc., Parsippany, NJ, USA), containing a minimum dosage of 1.2 mg/kg sarolaner, 24 µg/kg moxidectin, and 5 mg/kg pyrantel, against circulating microfilariae. Dogs naturally infected with heartworm and harbouring circulating microfilariae were enrolled in the study. Twelve dogs received a single treatment with Simparica Trio as per recommended label dosage, and efficacy was compared with an untreated control group of 10 dogs weekly for 28 days.
There were no adverse events recorded in this study. Following a single oral dose of Simparica Trio, a significant reduction in microfilaria counts in the Simparica Trio-treated group relative to the control group was first detected within 7 days (P < 0.0001), resulting in an efficacy of 99.9% (98.9%) based on geometric (arithmetic) means. The efficacy remained at least 99.9% (≥ 99.5%) based on geometric (arithmetic) means for 28 days (P < 0.0001).
A single oral dose of Simparica Trio was highly effective against circulating microfilariae in naturally infected dogs with D. immitis for 1 month. Combining its effects on migrating L₄ stages and circulating microfilariae coupled with mosquito killing, Simparica Trio offers a multimodal, holistic, integrated solution to heartworm prevention in dogs.

PMID:
42907840
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.